MediPharm Labs Corp. (TSX:LABS) is looking for acquisitions. Keith Strachan, President said, "We'll be looking at acquisitions that are already at least EBITDA positive, and that way we can bring them on and with probably a focusing more on that medical and international plant where we feel that we are best positioned to win".

David Pidduck, CEO said, "In 2023, we will continue to focus on reducing costs, driving revenue growth in selected segments, progressing our pharmaceutical milestone and pursuing synergistic M&A. We will remain focused on executing our strategy".